{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,17]],"date-time":"2026-10-17T04:06:22Z","timestamp":1792209982304,"version":"4.4.0"},"reference-count":58,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,12,17]],"date-time":"2025-12-17T00:00:00Z","timestamp":1765929600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,1,23]],"date-time":"2026-01-23T00:00:00Z","timestamp":1769126400000},"content-version":"vor","delay-in-days":37,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100005851","name":"Shahid Beheshti University of Medical Sciences","doi-asserted-by":"publisher","award":["NO. IR.SBMU.RIGLD.REC.1404.036"],"award-info":[{"award-number":["NO. IR.SBMU.RIGLD.REC.1404.036"]}],"id":[{"id":"10.13039\/501100005851","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Gastroenterol"],"DOI":"10.1186\/s12876-025-04551-1","type":"journal-article","created":{"date-parts":[[2025,12,17]],"date-time":"2025-12-17T23:03:34Z","timestamp":1766012614000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Exploring the biliary microbiome in hepatopancreatobiliary disorders: a comprehensive systematic review of microbial signatures and diagnostic potential"],"prefix":"10.1186","volume":"26","author":[{"given":"Hossein","family":"Halimi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zeinab","family":"Hesami","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nastaran","family":"Asri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Babak","family":"Khorsand","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammad","family":"Rostami-Nejad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6813-0229","authenticated-orcid":false,"given":"Hamidreza","family":"Houri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,12,17]]},"reference":[{"issue":"1","key":"4551_CR1","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1186\/s12889-024-17948-6","volume":"24","author":"XN Wu","year":"2024","unstructured":"Wu XN, Xue F, Zhang N, Zhang W, Hou JJ, Lv Y, et al. Global burden of liver cirrhosis and other chronic liver diseases caused by specific etiologies from 1990 to 2019. BMC Public Health. 2024;24(1):363.","journal-title":"BMC Public Health"},{"issue":"10","key":"4551_CR2","doi-asserted-by":"publisher","first-page":"e2018721","DOI":"10.1001\/jamanetworkopen.2020.18721","volume":"3","author":"Y Pang","year":"2020","unstructured":"Pang Y, Kartsonaki C, Lv J, Millwood IY, Yu C, Guo Y, et al. Observational and genetic associations of body mass index and hepatobiliary diseases in a relatively lean Chinese population. JAMA Netw Open. 2020;3(10):e2018721.","journal-title":"JAMA Netw Open"},{"issue":"9531","key":"4551_CR3","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1016\/S0140-6736(06)69044-2","volume":"368","author":"P Portincasa","year":"2006","unstructured":"Portincasa P, Moschetta A, Palasciano G. Cholesterol gallstone disease. Lancet. 2006;368(9531):230\u20139.","journal-title":"Lancet"},{"issue":"Suppl 1","key":"4551_CR4","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1111\/liv.14095","volume":"39","author":"SA Khan","year":"2019","unstructured":"Khan SA, Tavolari S, Brandi G. Cholangiocarcinoma: epidemiology and risk factors. Liver Int. 2019;39(Suppl 1):19\u201331.","journal-title":"Liver Int"},{"issue":"5","key":"4551_CR5","doi-asserted-by":"publisher","first-page":"e0322479","DOI":"10.1371\/journal.pone.0322479","volume":"20","author":"M Olfatifar","year":"2025","unstructured":"Olfatifar M, Rajabnia M, Sadeghi A, Rabbani A, Shahrokh S, Habibi MA, et al. The epidemiological trends and projected future of primary sclerosing cholangitis by 2040: an updated meta-analysis and modeling study. PLoS ONE. 2025;20(5):e0322479.","journal-title":"PLoS ONE"},{"issue":"12","key":"4551_CR6","doi-asserted-by":"publisher","first-page":"1161","DOI":"10.1056\/NEJMra1506330","volume":"375","author":"KN Lazaridis","year":"2016","unstructured":"Lazaridis KN, LaRusso NF. Primary sclerosing cholangitis. N Engl J Med. 2016;375(12):1161\u201370.","journal-title":"N Engl J Med"},{"issue":"20","key":"4551_CR7","doi-asserted-by":"publisher","first-page":"e70318","DOI":"10.1002\/cam4.70318","volume":"13","author":"Z Hesami","year":"2024","unstructured":"Hesami Z, Olfatifar M, Sadeghi A, Zali MR, Mohammadi-Yeganeh S, Habibi MA, et al. Global trend in pancreatic cancer prevalence rates through 2040: an Illness-Death modeling study. Cancer Med. 2024;13(20):e70318.","journal-title":"Cancer Med"},{"issue":"9","key":"4551_CR8","doi-asserted-by":"publisher","first-page":"2649","DOI":"10.1002\/cam4.767","volume":"5","author":"AS Quante","year":"2016","unstructured":"Quante AS, Ming C, Rottmann M, Engel J, Boeck S, Heinemann V, et al. Projections of cancer incidence and cancer-related deaths in Germany by 2020 and 2030. Cancer Med. 2016;5(9):2649\u201356.","journal-title":"Cancer Med"},{"issue":"9","key":"4551_CR9","first-page":"851","volume":"326","author":"W Park","year":"2021","unstructured":"Park W, Chawla A, O\u2019Reilly EM. Pancreat Cancer: Rev Jama. 2021;326(9):851\u201362.","journal-title":"Pancreat Cancer: Rev Jama"},{"issue":"5","key":"4551_CR10","doi-asserted-by":"publisher","first-page":"112314","DOI":"10.1016\/j.isci.2025.112314","volume":"28","author":"Z Hesami","year":"2025","unstructured":"Hesami Z, Sabzehali F, Khorsand B, Alipour S, Sadeghi A, Asri N, et al. Microbiota as a state-of-the-art approach in precision medicine for pancreatic cancer management: A comprehensive systematic review. iScience. 2025;28(5):112314.","journal-title":"iScience"},{"issue":"1","key":"4551_CR11","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1007\/s10238-025-01761-5","volume":"25","author":"B Khorsand","year":"2025","unstructured":"Khorsand B, Hesami Z, Alipour S, Farmani M, Houri H. Harnessing artificial intelligence for detection of pancreatic cancer: a machine learning approach. Clin Exp Med. 2025;25(1):228.","journal-title":"Clin Exp Med"},{"issue":"1","key":"4551_CR12","doi-asserted-by":"publisher","first-page":"624","DOI":"10.1186\/s12866-025-04344-2","volume":"25","author":"S Tavanaeian","year":"2025","unstructured":"Tavanaeian S, Feizabadi MM, Falsafi S, Aghdaei HA, Houri H. Oral and fecal Microbiome alterations in pancreatic cancer: insights into potential diagnostic biomarkers. BMC Microbiol. 2025;25(1):624.","journal-title":"BMC Microbiol"},{"key":"4551_CR13","doi-asserted-by":"publisher","first-page":"1678114","DOI":"10.3389\/fcimb.2025.1678114","volume":"15","author":"Z Hesami","year":"2025","unstructured":"Hesami Z, Pazienza V, Olfatifar M, Sadeghi A, Mohammadi-Yeganeh S, Trivieri N, et al. Integrated periodontal pathogens and Circulating mirnas: a novel non-invasive panel of biomarkers for pancreatic cancer. Front Cell Infect Microbiol. 2025;15:1678114.","journal-title":"Front Cell Infect Microbiol"},{"issue":"11","key":"4551_CR14","doi-asserted-by":"publisher","first-page":"719","DOI":"10.1038\/s41579-023-00904-3","volume":"21","author":"CL Hsu","year":"2023","unstructured":"Hsu CL, Schnabl B. The gut\u2013liver axis and gut microbiota in health and liver disease. Nat Rev Microbiol. 2023;21(11):719\u201333.","journal-title":"Nat Rev Microbiol"},{"key":"4551_CR15","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s40168-019-0712-8","volume":"7","author":"N Molinero","year":"2019","unstructured":"Molinero N, Ruiz L, Milani C, Guti\u00e9rrez-D\u00edaz I, S\u00e1nchez B, Mangifesta M, et al. The human gallbladder Microbiome is related to the physiological state and the biliary metabolic profile. Microbiome. 2019;7:1\u201317.","journal-title":"Microbiome"},{"key":"4551_CR16","doi-asserted-by":"publisher","first-page":"n71","DOI":"10.1136\/bmj.n71","volume":"372","author":"MJ Page","year":"2021","unstructured":"Page MJ, McKenzie JE, Bossuyt PM, Boutron I, Hoffmann TC, Mulrow CD, et al. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ. 2021;372:n71.","journal-title":"BMJ"},{"issue":"1","key":"4551_CR17","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1186\/s40001-023-01308-y","volume":"28","author":"X Cai","year":"2023","unstructured":"Cai X, Peng Y, Gong Y, Huang X, Liu L, Chen Y, et al. Variations of bile bacterial community alongside gallstone disease progression and key taxa involved in poor outcomes after endoscopic surgery. Eur J Med Res. 2023;28(1):313.","journal-title":"Eur J Med Res"},{"key":"4551_CR18","doi-asserted-by":"publisher","first-page":"122073","DOI":"10.1016\/j.lfs.2023.122073","volume":"331","author":"Q Liu","year":"2023","unstructured":"Liu Q, Zheng L, Wang Y, Huang Z, Zhu J, Fang M, et al. Primary choledocholithiasis occurrence and recurrence is synergetcally modulated by the bile Microbiome and metabolome alternations. Life Sci. 2023;331:122073.","journal-title":"Life Sci"},{"key":"4551_CR19","doi-asserted-by":"crossref","unstructured":"Choe JW, Lee JM, Hyun JJ, Lee HS. Analysis on microbial profiles & components of bile in patients with recurrent CBD stones after endoscopic CBD stone removal: A preliminary study. J Clin Med. 2021;10(15):3303.","DOI":"10.3390\/jcm10153303"},{"key":"4551_CR20","doi-asserted-by":"publisher","first-page":"4637560","DOI":"10.1155\/2020\/4637560","volume":"2020","author":"C Ye","year":"2020","unstructured":"Ye C, Zhou W, Zhang H, Miao L, Lv G. Alterations of the bile Microbiome in recurrent common bile duct stone. Biomed Res Int. 2020;2020:4637560.","journal-title":"Biomed Res Int"},{"key":"4551_CR21","doi-asserted-by":"publisher","first-page":"1259761","DOI":"10.3389\/fcimb.2023.1259761","volume":"13","author":"C Dai","year":"2023","unstructured":"Dai C, Xu C, Zheng L, Wang M, Fan Z, Ye J, et al. Characteristics and metabolic potential of biliary microbiota in patients with giant common bile duct stones. Front Cell Infect Microbiol. 2023;13:1259761.","journal-title":"Front Cell Infect Microbiol"},{"key":"4551_CR22","doi-asserted-by":"publisher","first-page":"881489","DOI":"10.3389\/fcimb.2022.881489","volume":"12","author":"R Feng","year":"2022","unstructured":"Feng R, Zhang T, Kayani MUR, Wang Z, Shen Y, Su KL, et al. Patients with primary and secondary bile duct stones harbor distinct biliary microbial composition and metabolic potential. Front Cell Infect Microbiol. 2022;12:881489.","journal-title":"Front Cell Infect Microbiol"},{"key":"4551_CR23","doi-asserted-by":"crossref","unstructured":"Park W, Park J. A comparative investigation of the bile Microbiome in patients with choledocholithiasis and cholecystolithiasis through metagenomic analysis. Int J Mol Sci. 2024;25(6):3297.","DOI":"10.3390\/ijms25063297"},{"issue":"4","key":"4551_CR24","doi-asserted-by":"publisher","first-page":"414","DOI":"10.1016\/j.synbio.2021.11.002","volume":"6","author":"Z Lyu","year":"2021","unstructured":"Lyu Z, Yu T, Zhang L, Xu X, Zhang Y, Li J, et al. Analysis of the relationship between bile duct and duodenal microbiota reveals that potential dysbacteriosis is the main cause of primary common bile duct stones. Synth Syst Biotechnol. 2021;6(4):414\u201328.","journal-title":"Synth Syst Biotechnol"},{"key":"4551_CR25","doi-asserted-by":"crossref","unstructured":"Lee J, Jeong HJ, Kim H, Park JS. The role of the bile Microbiome in common bile duct stone development. Biomedicines. 2023;11(8):2124.","DOI":"10.3390\/biomedicines11082124"},{"key":"4551_CR26","first-page":"1092563","volume":"2019","author":"B Chen","year":"2019","unstructured":"Chen B, Fu SW, Lu L, Zhao H. A preliminary study of biliary microbiota in patients with bile duct stones or distal cholangiocarcinoma. Biomed Res Int. 2019;2019:1092563.","journal-title":"Biomed Res Int"},{"issue":"5","key":"4551_CR27","first-page":"2962","volume":"14","author":"Z Li","year":"2022","unstructured":"Li Z, Chu J, Su F, Ding X, Zhang Y, Dou L, et al. Characteristics of bile microbiota in cholelithiasis, Perihilar cholangiocarcinoma, distal cholangiocarcinoma, and pancreatic cancer. Am J Transl Res. 2022;14(5):2962\u201371.","journal-title":"Am J Transl Res"},{"issue":"1","key":"4551_CR28","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1007\/s13755-023-00267-2","volume":"12","author":"F Liu","year":"2024","unstructured":"Liu F, Wang ZK, Li MY, Zhang XL, Cai FC, Wang XD, et al. Characterization of biliary and duodenal microbiota in patients with primary and recurrent choledocholithiasis. Health Inf Sci Syst. 2024;12(1):29.","journal-title":"Health Inf Sci Syst"},{"issue":"10","key":"4551_CR29","doi-asserted-by":"publisher","first-page":"576","DOI":"10.21037\/atm-22-2247","volume":"10","author":"W Tan","year":"2022","unstructured":"Tan W, Chen R, Song J, He D, Wu J, Chen X, et al. Microbiota analysis with next-generation 16S rDNA gene sequencing in recurrent common bile duct stones. Ann Transl Med. 2022;10(10):576.","journal-title":"Ann Transl Med"},{"issue":"12","key":"4551_CR30","doi-asserted-by":"publisher","first-page":"1257","DOI":"10.3748\/wjg.v28.i12.1257","volume":"28","author":"Y Li","year":"2022","unstructured":"Li Y, Tan WH, Wu JC, Huang ZX, Shang YY, Liang B, et al. Microbiologic risk factors of recurrent choledocholithiasis post-endoscopic sphincterotomy. World J Gastroenterol. 2022;28(12):1257\u201371.","journal-title":"World J Gastroenterol"},{"issue":"15","key":"4551_CR31","doi-asserted-by":"publisher","first-page":"e94","DOI":"10.3346\/jkms.2021.36.e94","volume":"36","author":"B Kim","year":"2021","unstructured":"Kim B, Park JS, Bae J, Hwang N. Bile microbiota in patients with pigment common bile duct stones. J Korean Med Sci. 2021;36(15):e94.","journal-title":"J Korean Med Sci"},{"key":"4551_CR32","doi-asserted-by":"publisher","first-page":"844401","DOI":"10.3389\/fimmu.2022.844401","volume":"13","author":"Z Chen","year":"2022","unstructured":"Chen Z, Zhang S, Dong S, Xu H, Zhou W. Association of the microbiota and pancreatic cancer: opportunities and limitations. Front Immunol. 2022;13:844401.","journal-title":"Front Immunol"},{"issue":"4","key":"4551_CR33","doi-asserted-by":"publisher","first-page":"e0283021","DOI":"10.1371\/journal.pone.0283021","volume":"18","author":"SK Poudel","year":"2023","unstructured":"Poudel SK, Padmanabhan R, Dave H, Guinta K, Stevens T, Sanaka MR, et al. Microbiomic profiles of bile in patients with benign and malignant pancreaticobiliary disease. PLoS ONE. 2023;18(4):e0283021.","journal-title":"PLoS ONE"},{"key":"4551_CR34","doi-asserted-by":"crossref","unstructured":"Merali N, Chouari T, Terroire J, Jessel MD, Liu DSK, Smith JH, et al. Bile Microbiome signatures associated with pancreatic ductal adenocarcinoma compared to benign disease: A UK pilot study. Int J Mol Sci. 2023;24(23):16888.","DOI":"10.3390\/ijms242316888"},{"key":"4551_CR35","doi-asserted-by":"publisher","first-page":"715536","DOI":"10.3389\/fphys.2021.715536","volume":"12","author":"B Rao","year":"2021","unstructured":"Rao B, Ren T, Wang X, Wang H, Zou Y, Sun Y, et al. Dysbiosis in the human Microbiome of cholangiocarcinoma. Front Physiol. 2021;12:715536.","journal-title":"Front Physiol"},{"issue":"1","key":"4551_CR36","doi-asserted-by":"publisher","first-page":"233","DOI":"10.31557\/APJCP.2021.22.1.233","volume":"22","author":"R Dangtakot","year":"2021","unstructured":"Dangtakot R, Intuyod K, Ahooja A, Wongwiwatchai J, Hanpanich P, Lulitanond A, et al. Profiling of bile Microbiome identifies district microbial population between choledocholithiasis and cholangiocarcinoma patients. Asian Pac J Cancer Prevention: APJCP. 2021;22(1):233.","journal-title":"Asian Pac J Cancer Prevention: APJCP"},{"issue":"9","key":"4551_CR37","doi-asserted-by":"publisher","first-page":"2120","DOI":"10.3390\/cancers14092120","volume":"14","author":"K Miyabe","year":"2022","unstructured":"Miyabe K, Chandrasekhara V, Wongjarupong N, Chen J, Yang L, Johnson S, et al. Potential role of inflammation-promoting biliary Microbiome in primary sclerosing cholangitis and cholangiocarcinoma. Cancers. 2022;14(9):2120.","journal-title":"Cancers"},{"issue":"2","key":"4551_CR38","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1016\/j.cmi.2015.10.008","volume":"22","author":"F Avil\u00e9s-Jim\u00e9nez","year":"2016","unstructured":"Avil\u00e9s-Jim\u00e9nez F, Guitron A, Segura-L\u00f3pez F, M\u00e9ndez-Tenorio A, Iwai S, Hern\u00e1ndez-Guerrero A, et al. Microbiota studies in the bile duct strongly suggest a role for Helicobacter pylori in extrahepatic cholangiocarcinoma. Clin Microbiol Infect. 2016;22(2):178.e11-.e22.","journal-title":"Clin Microbiol Infect"},{"issue":"3","key":"4551_CR39","doi-asserted-by":"publisher","first-page":"e0247798","DOI":"10.1371\/journal.pone.0247798","volume":"16","author":"M Saab","year":"2021","unstructured":"Saab M, Mestivier D, Sohrabi M, Rodriguez C, Khonsari MR, Faraji A, et al. Characterization of biliary microbiota dysbiosis in extrahepatic cholangiocarcinoma. PLoS ONE. 2021;16(3):e0247798.","journal-title":"PLoS ONE"},{"key":"4551_CR40","doi-asserted-by":"crossref","unstructured":"\u00d6zdirik B, M\u00fcller T, Wree A, Tacke F, Sigal M. The role of microbiota in primary sclerosing cholangitis and related biliary malignancies. Int J Mol Sci. 2021;22(13):6975.","DOI":"10.3390\/ijms22136975"},{"issue":"3","key":"4551_CR41","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1016\/j.jcmgh.2023.12.005","volume":"17","author":"B \u00d6zdirik","year":"2024","unstructured":"\u00d6zdirik B, Schnabl B. Microbial players in primary sclerosing cholangitis: current evidence and concepts. Cell Mol Gastroenterol Hepatol. 2024;17(3):423\u201338.","journal-title":"Cell Mol Gastroenterol Hepatol"},{"issue":"4","key":"4551_CR42","doi-asserted-by":"publisher","first-page":"665","DOI":"10.1136\/gutjnl-2019-318416","volume":"69","author":"T Liwinski","year":"2020","unstructured":"Liwinski T, Zenouzi R, John C, Ehlken H, R\u00fchlemann MC, Bang C, et al. Alterations of the bile Microbiome in primary sclerosing cholangitis. Gut. 2020;69(4):665\u201372.","journal-title":"Gut"},{"issue":"8","key":"4551_CR43","doi-asserted-by":"publisher","first-page":"e0182924","DOI":"10.1371\/journal.pone.0182924","volume":"12","author":"P Pereira","year":"2017","unstructured":"Pereira P, Aho V, Arola J, Boyd S, Jokelainen K, Paulin L, et al. Bile microbiota in primary sclerosing cholangitis: impact on disease progression and development of biliary dysplasia. PLoS ONE. 2017;12(8):e0182924.","journal-title":"PLoS ONE"},{"key":"4551_CR44","doi-asserted-by":"crossref","unstructured":"Binda C, Gibiino G, Coluccio C, Sbrancia M, Dajti E, Sinagra E, et al. Biliary diseases from the Microbiome perspective: how microorganisms could change the approach to benign and malignant diseases. Microorganisms. 2022;10(2):312.","DOI":"10.3390\/microorganisms10020312"},{"issue":"9","key":"4551_CR45","doi-asserted-by":"publisher","first-page":"3453","DOI":"10.1128\/JCM.01207-14","volume":"52","author":"M Drancourt","year":"2014","unstructured":"Drancourt M, Prebet T, Aghnatios R, Edouard S, Cayrou C, Henry M, et al. Planctomycetes DNA in febrile aplastic patients with leukemia, rash, diarrhea, and micronodular pneumonia. J Clin Microbiol. 2014;52(9):3453\u20135.","journal-title":"J Clin Microbiol"},{"issue":"5","key":"4551_CR46","doi-asserted-by":"publisher","first-page":"580","DOI":"10.1111\/apt.15375","volume":"50","author":"M R\u00fchlemann","year":"2019","unstructured":"R\u00fchlemann M, Liwinski T, Heinsen FA, Bang C, Zenouzi R, Kummen M, et al. Consistent alterations in faecal microbiomes of patients with primary sclerosing cholangitis independent of associated colitis. Aliment Pharmacol Ther. 2019;50(5):580\u20139.","journal-title":"Aliment Pharmacol Ther"},{"issue":"3","key":"4551_CR47","doi-asserted-by":"publisher","first-page":"238","DOI":"10.18683\/germs.2023.1390","volume":"13","author":"M Azimirad","year":"2023","unstructured":"Azimirad M, Sadeghi A, Hosseinkhan N, Mirbagheri SZ, Alebouyeh M. Microbiome analysis of bile samples in patients with choledocholithiasis and hepatobiliary disorders. Germs. 2023;13(3):238.","journal-title":"Germs"},{"issue":"1","key":"4551_CR48","doi-asserted-by":"publisher","first-page":"1019","DOI":"10.1038\/s42003-021-02557-5","volume":"4","author":"W Guo","year":"2021","unstructured":"Guo W, Zhang Y, Guo S, Mei Z, Liao H, Dong H, et al. Tumor Microbiome contributes to an aggressive phenotype in the basal-like subtype of pancreatic cancer. Commun Biology. 2021;4(1):1019.","journal-title":"Commun Biology"},{"issue":"4","key":"4551_CR49","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1158\/2159-8290.CD-17-1134","volume":"8","author":"S Pushalkar","year":"2018","unstructured":"Pushalkar S, Hundeyin M, Daley D, Zambirinis CP, Kurz E, Mishra A, et al. The pancreatic cancer Microbiome promotes oncogenesis by induction of innate and adaptive immune suppression. Cancer Discov. 2018;8(4):403\u201316.","journal-title":"Cancer Discov"},{"key":"4551_CR50","unstructured":"Suman S, Vogtmann E, Bokulich N, Kamangar F, Hicks B. Oral microbial community composition is associated with pancreatic cancer: A case-control study in Iran. Cancer Med. 2021."},{"issue":"6","key":"4551_CR51","doi-asserted-by":"publisher","first-page":"709","DOI":"10.1002\/bjs.12003","volume":"108","author":"M Weniger","year":"2021","unstructured":"Weniger M, Hank T, Qadan M, Ciprani D, Michelakos T, Niess H, et al. Influence of Klebsiella pneumoniae and quinolone treatment on prognosis in patients with pancreatic cancer. Br J Surg. 2021;108(6):709\u201316.","journal-title":"Br J Surg"},{"issue":"2","key":"4551_CR52","doi-asserted-by":"publisher","first-page":"208","DOI":"10.1093\/cid\/cix270","volume":"65","author":"CL Gorrie","year":"2017","unstructured":"Gorrie CL, Mirceta M, Wick RR, Edwards DJ, Thomson NR, Strugnell RA, et al. Gastrointestinal carriage is a major reservoir of Klebsiella pneumoniae infection in intensive care patients. Clin Infect Dis. 2017;65(2):208\u201315.","journal-title":"Clin Infect Dis"},{"key":"4551_CR53","doi-asserted-by":"crossref","unstructured":"Stein-Thoeringer CK, Renz BW, De Castilhos J, von Ehrlich-Treuenst\u00e4tt V, Wirth U, Tschaidse T et al. Microbiome dysbiosis with Enterococcus presence in the upper Gastrointestinal tract is A risk factor for mortality in patients undergoing surgery for pancreatic cancer. Ann Surg. 2024.","DOI":"10.1097\/SLA.0000000000006210"},{"key":"4551_CR54","doi-asserted-by":"publisher","first-page":"107928","DOI":"10.1016\/j.micpath.2025.107928","volume":"207","author":"F Rafiei","year":"2025","unstructured":"Rafiei F, Ghalavand Z, Alipour S, Sadeghi A, Eslami G, Houri H. Enhanced virulence and pro-inflammatory potential of bile-derived Escherichia coli and Klebsiella pneumoniae isolates in primary sclerosing cholangitis: implications for disease pathogenesis. Microb Pathog. 2025;207:107928.","journal-title":"Microb Pathog"},{"issue":"6","key":"4551_CR55","doi-asserted-by":"publisher","first-page":"814","DOI":"10.14309\/ajg.0000000000000604","volume":"115","author":"A Shah","year":"2020","unstructured":"Shah A, Macdonald GA, Morrison M, Holtmann G. Targeting the gut Microbiome as a treatment for primary sclerosing cholangitis: A conceptional framework. Am J Gastroenterol. 2020;115(6):814\u201322.","journal-title":"Am J Gastroenterol"},{"key":"4551_CR56","doi-asserted-by":"crossref","unstructured":"Shi Q, Yuan X, Zeng Y, Wang J, Zhang Y, Xue C, et al. Crosstalk between gut microbiota and bile acids in cholestatic liver disease. Nutrients. 2023;15(10):2411.","DOI":"10.3390\/nu15102411"},{"issue":"1","key":"4551_CR57","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1186\/s10020-024-00830-x","volume":"30","author":"D sun","year":"2024","unstructured":"sun D, Xie C, Zhao Y, Liao J, Li S, Zhang Y, et al. The gut microbiota-bile acid axis in cholestatic liver disease. Mol Med. 2024;30(1):104.","journal-title":"Mol Med"},{"issue":"1","key":"4551_CR58","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1186\/s40168-017-0237-y","volume":"5","author":"S Weiss","year":"2017","unstructured":"Weiss S, Xu ZZ, Peddada S, Amir A, Bittinger K, Gonzalez A, et al. Normalization and microbial differential abundance strategies depend upon data characteristics. Microbiome. 2017;5(1):27.","journal-title":"Microbiome"}],"container-title":["BMC Gastroenterology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12876-025-04551-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12876-025-04551-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12876-025-04551-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,23]],"date-time":"2026-01-23T13:03:01Z","timestamp":1769173381000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12876-025-04551-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,17]]},"references-count":58,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["4551"],"URL":"https:\/\/doi.org\/10.1186\/s12876-025-04551-1","relation":{},"ISSN":["1471-230X"],"issn-type":[{"value":"1471-230X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12,17]]},"assertion":[{"value":"21 March 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 December 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 December 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"55"}}